VRTX
Vertex Pharmaceuticals Incorporated
NASDAQ · Healthcare · Biotechnology · US
$546.12
−2.12%Leverage
- Debt / equity
- 0.10x
- Net debt / equity
- -0.21x
- Debt / assets
- 0.07x
- Debt / EBITDA
- 0.36x
- Net debt / EBITDA
- -0.77x
Liquidity & coverage
- Current ratio
- 3.19x
- Quick ratio
- 2.74x
- Cash ratio
- 1.99x
- Interest coverage
- 738.18x
- EBITDA / interest
- 824.92x
- Working capital
- $8.6B
Cash & dividend
- FCF / debt
- 1.92x
- Cash flow / debt
- 2.17x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026